#Pharmaceutical Analytical Testing Outsourcing Market

[industrynewsupdates]

Pharmaceutical Analytical Testing Outsourcing Market 2024-2030: Trends and Opportunities

The global pharmaceutical analytical testing outsourcing market size was valued at USD 8.3 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030.

Growth in the market can be attributed due to increasing focus toward safety, & quality; regulation, pricing benefits of outsourcing, and rising number of end use. Besides, increasing R&D investment is one of the critical sustainability strategies adopted by market players. As, not all companies have an infrastructure for analytical testing. Therefore, outsourcing these operations is a suitable option, which helps to save time and cost.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Analytical Testing Outsourcing Market 

Other factors, such as the changing regulations for in vivo and in vitro tests, are also expected to propel the growth of the market for pharmaceutical analytical testing outsourcing. Besides, high demand for quality generic drugs, analytical testing methods, improved the quality and transparency of the review & approval process, and encourage new drug R&D in line with global development is anticipated to fuel the market growth.

In addition, innovation or new product development is directly proportional to the demand for testing services due to pricing concerns, competitive pressures, and lead-time to market, companies are opting for outsourcing of testing services. Moreover, focus on customized care and technological advancements, which has resulted in rapid development of new products. Likewise, development of biosimilar, combination products, and other innovative medicines has fueled the demand for pharmaceutical analytical testing services.  

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global pharmaceutical regulatory affairs market size was estimated at USD 8.84 billion in 2023 and is projected to grow at a CAGR of 7.16% from 2024 to 2030. 

• The global pharmaceutical packaging market size was valued at USD 139.37 billion in 2023 and is expected to grow a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030.

Pharmaceutical Analytical Testing Outsourcing Market Segmentation

Grand View Research has segmented the prebiotic ingredient market based on type, application, and region:

Type Outlook (Revenue, USD Million, 2017 - 2028)

• Inulin

• Oligosaccharide (MOS/GOS/FOS)

• Others

Applications Outlook (Revenue, USD Million, 2017 - 2028)

• Food & Beverage

• Dietary Supplements

• Others

Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America

• Europe

• Asia Pacific

• Central & South America

• Middle East & Africa

Key Companies & Market Share Insights

Companies' are focusing on innovating new types of prebiotic ingredients to meet the increasing demand. New players are entering the market owing to low market entry barriers and higher market potential. The increasing demand for prebiotic ingredients offers an opportunity for product development in the regions of high demand. Some of the prominent players in the global prebiotic ingredient market include:

• Beneo-Orafti SA

• Tereos Group

• Ingredion Inc.

• Cargill Inc.

• DowDuPont Inc

• Royal FrieslandCampina N.V.

• Kerry Group

• Cosucra-groupe Warcoing SA

• Sensus BV

Recent Developments

• In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.

• In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, providing support in the early stages of pharmaceutical product development.

Order a free sample PDF of the Pharmaceutical Analytical Testing Outsourcing Market Intelligence Study, published by Grand View Research. 

[blog-site-for-market-research]

Market Report: Delving into the Pharmaceutical Analytical Testing Outsourcing Market Size and Share

Market Overview –

The Pharmaceutical Analytical Testing Outsourcing Market refers to the sector within the pharmaceutical industry where companies outsource their analytical testing needs to specialized service providers. This market has witnessed significant growth in recent years due to the increasing complexity of drug formulations and the stringent regulatory requirements imposed by health authorities worldwide.

Outsourcing Analytical Testing in the pharmaceutical industry is witnessing significant traction as companies seek cost-effective and specialized solutions. Outsourcing firms offer expertise in analytical testing, ensuring regulatory compliance and quality assurance. This trend is driven by the complexity of testing requirements and the need for efficient resource allocation. The market for outsourcing analytical testing services is expected to continue growing as pharmaceutical companies prioritize core activities and seek external expertise.

Companies outsource analytical testing to gain access to state-of-the-art facilities, expertise, and specialized technologies without the need for heavy investments in infrastructure and personnel training. This trend is particularly pronounced among smaller pharmaceutical companies and startups with limited resources.

Key players in the Pharmaceutical Analytical Testing Outsourcing Market include contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and independent analytical laboratories. These entities offer a wide range of services, including method development and validation, stability testing, raw material testing, and quality control testing.

Factors driving the growth of this market include the increasing globalization of the pharmaceutical industry, the rising demand for specialized analytical techniques such as mass spectrometry and chromatography, and the growing emphasis on outsourcing non-core activities to focus on core competencies.

Despite the opportunities, the market faces challenges such as data security concerns, quality control issues, and the need for regulatory compliance. However, with the right strategies in place, the Pharmaceutical Analytical Testing Outsourcing Market is poised for continued growth and innovation in the coming years.

In 2022, the pharmaceutical analytical testing outsourcing market was estimated to be worth USD 4.2 billion. According to projections, the pharmaceutical analytical testing outsourcing market is expected to increase at a compound annual growth rate (CAGR) of 8.70% from USD 4.6 billion in 2023 to USD 7.5 billion by 2030.

Segmentation –

The global pharmaceutical analytical testing outsourcing market, by product type, has been segmented into finished products, active pharmaceutical ingredients, and raw materials. The finished products segment accounted for a value of USD 2,055.4 million in 2017. The market, by services, can be segmented into bioanalytical testing, method development & validation, stability testing, and others. On the basis of end user, the global pharmaceutical analytical testing outsourcing market is segmented into pharmaceutical & biopharmaceutical companies and biotechnology industry.

Regional Analysis –

The Pharmaceutical Analytical Testing Outsourcing Market exhibits diverse regional trends influenced by factors such as regulatory frameworks, technological advancements, and the presence of outsourcing service providers.

North America dominates the market, driven by stringent regulatory requirements, a robust pharmaceutical industry, and a high demand for outsourcing services to ensure compliance and product quality. The region also benefits from a mature outsourcing ecosystem and a strong network of contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). Similarly, Europe holds a significant market share, supported by a well-established pharmaceutical sector, favorable regulatory environment, and increasing emphasis on cost-effective solutions.

In Asia Pacific, the market is witnessing rapid growth fueled by the outsourcing trend among pharmaceutical companies, expanding healthcare infrastructure, and a skilled workforce at competitive costs. Latin America and the Middle East & Africa regions present opportunities for market expansion, driven by the growing pharmaceutical industry, improving regulatory landscape, and cost advantages. However, challenges such as quality control issues and intellectual property concerns may impact market growth in these regions. Overall, the Pharmaceutical Analytical Testing Outsourcing Market showcases a dynamic landscape across different regions, characterized by varying regulatory environments, outsourcing capabilities, and market demands.

Key Players –

Pharmaceutical analytical testing outsourcing companies include Boston Analytical (New Hampshire), West Pharmaceutical Services, Inc. (U.S.), Exova Group PLC (U.K.), Source BioScience (U.K.), Pace Analytical Services, Inc. (U.S.), Merck KGaA (Germany), WuXi AppTec (U.S.), Toxikon (U.S.), Eurofins Scientific (Belgium and Luxembourg), Intertek Group Plc (U.K.), Charles River Laboratories International, Inc (U.S.), SGS SA (U.K.), and Pharmaceutical Product Development, LLC (U.S.).

Related Reports –

Neurostimulation Devices

Crohn’s Disease

Healthcare Biometrics

Osteoporosis Drugs

For more information visit at MarketResearchFuture

[medicaldevicesindustrynews]

North America Had the Largest Share of Around 53% in Pharmaceutical Analytical Testing Outsourcing Market

North America Had the Largest Share of Around 53% in Pharmaceutical Analytical Testing Outsourcing Market

The size of the pharmaceutical analytical testing outsourcing market in 2021 was $7,594.3 million, and it will advance at a growth rate of around 9% in the years to come, reaching around $15,815 million by 2030. This has a lot to do with the innovations in the pharmacological industry; the augmented emphasis on safety, regulation, and eminence; the increase in the number of users; and the…

[marketreports-blog]

The U.S. pharmaceutical analytical testing outsourcing market size was exhibited at USD 4.50 billion in 2023 and is projected to hit around USD 9.07 billion by 2032, growing at a CAGR of 8.1% during the forecast period 2023 to 2032.

[luckydige45]

The U.S. pharmaceutical analytical testing outsourcing market size was exhibited at USD 4.50 billion in 2023 and is projected to hit around USD 9.07 billion by 2032, growing at a CAGR of 8.1% during the forecast period 2023 to 2032.

[mordormr]

The Growing Importance of the Pharmaceutical Analytical Testing Market

The Pharmaceutical Analytical Testing Market is projected to be valued at USD 8.98 billion in 2024 and is expected to grow to USD 13.43 billion by 2029, with a compound annual growth rate (CAGR) of 8.41% during the forecast period (2024-2029).

The Pharmaceutical Analytical Testing Market is experiencing robust growth, driven by the rising demand for safe and effective medicines, stricter regulatory standards, and the increasing complexity of drug development. As pharmaceutical companies focus on innovation and compliance, the need for rigorous analytical testing services has never been more critical.

What is Pharmaceutical Analytical Testing?

Pharmaceutical analytical testing involves a broad range of procedures and tests aimed at ensuring the safety, quality, and efficacy of pharmaceutical products. These services encompass chemical, physical, and microbiological testing and are essential throughout the drug development lifecycle, from raw material verification to final product release.

Key Market Drivers

Rising Drug Development and Outsourcing Trends The global surge in drug development activities, particularly in areas like oncology, immunology, and rare diseases, has significantly boosted the demand for analytical testing services. As drug development becomes more complex, many pharmaceutical companies are increasingly outsourcing these services to specialized laboratories to focus on core research and development (R&D) efforts. This has led to a boom in contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs), both of which offer analytical testing as part of their comprehensive services.

Stringent Regulatory Requirements Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are enforcing stricter regulations on drug safety and quality. Compliance with Good Manufacturing Practice (GMP) standards and thorough documentation is now a non-negotiable aspect of pharmaceutical development. As a result, pharmaceutical companies must conduct detailed testing at every stage, from early-stage clinical trials to post-market surveillance, driving the need for advanced analytical testing solutions.

Advancements in Analytical Technologies Technological advancements in testing methods, such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR), are transforming the industry. These innovations offer more precise and accurate data, enabling quicker and more cost-effective testing. Furthermore, the integration of automation and artificial intelligence (AI) is further streamlining testing processes, reducing human error, and accelerating drug approvals.

Growing Biopharmaceutical Sector The rise of biologics and biosimilars has added new dimensions to the pharmaceutical industry. Biopharmaceutical products, due to their complex structures, require more sophisticated testing methodologies. Analytical testing for biopharmaceuticals focuses on characterizing the biologic molecule, ensuring stability, and monitoring for any impurities. This shift is creating new opportunities for growth in the analytical testing market.

Increased Focus on Personalized Medicine The pharmaceutical industry is moving towards personalized medicine, where treatments are tailored to individual patient needs. Analytical testing plays a critical role in developing these customized therapies by helping to identify specific biomarkers, measure drug efficacy, and ensure the safety of tailored treatment options.

Market Challenges

High Costs and Time-Consuming Processes While essential, pharmaceutical analytical testing can be a costly and time-intensive process. Developing cutting-edge testing methods and equipment requires significant investment, and maintaining compliance with ever-evolving regulations adds to operational expenses. These factors can pose challenges, particularly for smaller pharmaceutical companies with limited resources.

Complexities of Biosimilar and Biologic Testing Testing biologics and biosimilars is inherently more complex than traditional small-molecule drugs. As biologics are produced using living cells, ensuring consistency, purity, and potency is more difficult, and advanced analytical techniques are required. This increases the demand for specialized expertise, which may not always be readily available.

Future Trends in the Pharmaceutical Analytical Testing Market

Expansion of Testing for Emerging Therapies As the development of cell and gene therapies accelerates, the analytical testing market is poised to expand further. These therapies require innovative testing strategies due to their novel mechanisms of action, which adds another layer of complexity to the analytical process.

Adoption of Green Chemistry The pharmaceutical industry is increasingly adopting sustainable practices, including green chemistry principles, to reduce environmental impact. This shift is likely to influence the analytical testing landscape, with new methods focusing on minimizing waste and reducing the use of hazardous substances.

Growth in Emerging Markets Emerging markets, particularly in Asia-Pacific, Latin America, and Eastern Europe, are experiencing significant growth in pharmaceutical manufacturing and R&D activities. These regions are expected to contribute to the expansion of the analytical testing market as companies seek cost-effective testing solutions to meet global regulatory standards.

Conclusion

The pharmaceutical analytical testing market is on an upward trajectory, supported by advancements in technology, the rising demand for biopharmaceuticals, and stricter regulatory environments. As the pharmaceutical industry evolves with emerging therapies and personalized medicine, the role of analytical testing will only become more crucial. Companies that invest in innovative testing methods and embrace the evolving regulatory landscape will be best positioned to capitalize on the growth opportunities in this dynamic market.

This blog explores the critical role that pharmaceutical analytical testing plays in ensuring the safety and efficacy of drugs, highlighting the key drivers, challenges, and future trends shaping the market.

[lanettcdmo]

The Role of Contract Development and Manufacturing Organizations (CDMOs) in the Pharmaceutical

 

 Introduction

In the ever-evolving pharmaceutical and biotech industries, Contract Development and Manufacturing Organizations (CDMOs) have become essential players. They support drug developers by offering a comprehensive range of services, from initial drug development to large-scale production. In this blog, we’ll explore the role, benefits, and trends of CDMOs.

1. What is a CDMO?

A Contract Development and Manufacturing Organization (CDMO) is a company that offers services ranging from drug development to manufacturing, enabling pharmaceutical firms to outsource parts of their process. CDMOs are often seen as critical partners for both small biotech startups and large pharmaceutical companies.

Services Offered by CDMOs:

Drug Development: Preclinical and clinical development, formulation.

Analytical Services: Quality control, stability testing, regulatory support.

Manufacturing: Production at various scales (pilot, clinical, commercial).

Packaging and Distribution.

2. Why CDMOs are Critical to the Pharma Industry

Pharmaceutical companies increasingly turn to CDMOs for reasons including:

Cost Efficiency: Outsourcing reduces infrastructure and labor costs.

Speed to Market: Accelerates development timelines by leveraging expertise.

Focus on Core Strengths: Allows pharma companies to focus on innovation and commercialization rather than in-house production.

3. Key Advantages of Working with CDMOs

Expertise and Experience: CDMOs possess technical and regulatory expertise.

Flexibility and Scalability: They offer scalable solutions tailored to the project's needs, whether for small-scale clinical batches or full-scale commercial production.

Regulatory Compliance: CDMOs are well-versed in global regulatory standards, ensuring compliance with FDA, EMA, and other bodies.

4. CDMOs and Biotech Startups

For small biotechnology firms with limited resources, CDMOs provide access to cutting-edge technologies and capabilities. Startups can avoid significant capital investment by outsourcing drug development and manufacturing, focusing on research and innovation.

5. Trends in the CDMO Industry

The CDMO sector continues to evolve with the following trends shaping its future:

Biologics and Advanced Therapies: The rise of biologics, cell, and gene therapies has driven demand for specialized CDMOs.

Digitalization: The integration of AI, IoT, and data analytics is improving efficiency and quality control.

Sustainability and Green Manufacturing: As environmental concerns grow, CDMOs are adopting eco-friendly manufacturing practices.

Partnerships and Consolidations: Mergers and acquisitions have increased as CDMOs expand capabilities and global reach.

6. How to Choose the Right CDMO Partner

Selecting the right CDMO is critical for successful drug development and manufacturing. Key factors include:

Technical Expertise: Ensure the CDMO has the required technical and regulatory knowledge for your specific product type.

Track Record: Check their experience in handling similar projects.

Capacity and Flexibility: Verify whether the CDMO can scale up production if needed.

Quality Standards and Compliance: Ensure they follow GMP guidelines and other regulatory requirements.

Conclusion

As pharmaceutical companies look for ways to streamline their operations and bring new therapies to market faster, CDMOs will continue to play a pivotal role. By providing essential services at various stages of drug development and manufacturing, they are indispensable partners in the journey from laboratory to patient.

[industrynewsupdates]

Clinical Trials Procurement Intelligence 2024-2030: What You Need to Know

This clinical trials market is anticipated to grow at a CAGR of 6.49% from 2024 to 2030. North America is the leading region in this category, accounting for over 50.3% of the market share in 2023. This is expected to continue in the forecast period as well, due to several factors, including increased R&D investments and the adoption of new technologies. For example, the use of virtual services in clinical trials is becoming increasingly popular, and this is expected to drive growth in the North American market.

This category is driven by many key factors, including the surge in demand for outsourcing clinical trials, the increasing prevalence of chronic diseases, and the increased investments in R&D by pharmaceutical and biotechnological companies. The outsourcing of this category is becoming increasingly popular, as it allows pharmaceutical companies to focus on their core competencies and to save time and money. The increasing prevalence of chronic diseases is also driving the demand for clinical trials, as there is a need for the development of new and efficient therapeutics to treat these diseases. Also, the increased investments in R&D by pharmaceutical and biotechnological companies are driving the growth of the market, as these companies are constantly developing new drugs and therapies that need to be tested in clinical trials.

This category is a moderately fragmented market due to the presence of numerous players. Strategic alliances between pharmaceutical firms and CROs are anticipated to have a substantial impact on the category’s expansion. Additionally, the swift uptake of new technology for better healthcare contributes to the market's expansion. For instance,

• In November 2022, Calit Health Services (Israel) and IQVIA (US) announced a collaboration to work on clinical trial delivery. The collaboration will combine Calit's extensive clinical trial experience and IQVIA's global reach and expertise in data analytics.

• In April 2022, Charles River Laboratories, a pharmaceutical company that provides preclinical and clinical laboratory services, acquired Explora BioLabs, a provider of contract vivarium research services. This acquisition will allow Charles River to expand its offerings in the cell and gene therapy space.

• In February 2022, Citeline and Norstella merged to form a new company worth $5 billion. Citeline provides clinical trial management software, while Norstella provides clinical trial supplies and services. The merger of these two companies will allow them to offer a more comprehensive suite of services to pharmaceutical companies, which could help speed up the drug development process and improve patient access to new therapies.

Order your copy of the Clinical Trials Procurement Intelligence Report, 2024 - 2030, published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis

Technological advancements in this category have revolutionized the drug development process by reducing costs and increasing efficiency. With rising trial expenses, failure rates, and a focus on patient-centric trials, the demand for the technology in clinical trials has surged. The landscape of clinical trials is evolving towards decentralization with the utilization of wearables, mHealth, and real-world evidence (RWE). These disruptive technologies enable small, controlled trials and streamline processes from patient enrollment to medication administration and follow-ups through mobile devices. Pharmaceutical companies are investing heavily in AI and big data analytics to leverage their transformative impact on the R&D process, enhance competitiveness, and facilitate company transformation and agility. Additionally, the integration of wearable devices and remote sample collection offers a safer and more convenient experience for participants, potentially increasing patient enrollment and engagement in future studies.

Defining the price and cost of this category is complex as it is dependent on various factors like phase, drug type, and location. Costs range from millions to billions, divided into patient care and research costs. Patient care costs include recruitment, enrollment, medication, safety monitoring, while research costs cover design, implementation, data analysis, and results publication. When budgeting for a clinical trial, consider various cost segments like regulatory, safety, data, quality management, overhead, and site costs. The price of this category is determined by the trial sponsor, typically a pharmaceutical company. Various factors can influence the trial's price, including its scale, complexity, and associated risks. Sponsors take these factors into account when setting the price, as they impact the resources required to conduct a successful trial.

When it comes to sourcing of this category, it is crucial to follow the best practices to ensure the high quality and integrity of the study. These practices include identifying reputable trial sites, evaluating investigator qualifications, prioritizing patient safety, assessing site capabilities, reviewing ethical considerations, evaluating data management systems, monitoring compliance with regulations, conducting site visits and audits. Additionally, it is essential to prioritize suppliers who offer comprehensive documentation, including certificates of analysis and trials conducted. By following these best practices, sponsors can enhance the quality, reliability, and ethical standards of their clinical trials. Finally, considering suppliers who engage in continuous research and development efforts can be beneficial for this category.

Clinical Trials Procurement Intelligence Report scope

• Clinical Trials Category Growth Rate: CAGR of 6.49% from 2024 to 2030

• Pricing Growth Outlook: 2% - 3% (Annually)

• Pricing Models: Unit-based pricing

• Supplier Selection Scope: Cost and pricing, Past engagements, Productivity, Geographical presence

• Supplier selection criteria: Reviewing ethical considerations, prioritizing patient safety, regulatory standards and mandates, category innovations, and others

• Report Coverage: Revenue forecast, supplier ranking, supplier matrix, emerging technology, pricing models, cost structure, competitive landscape, growth factors, trends, engagement, and operating model

Browse through Grand View Research’s collection of procurement intelligence studies:

• Clinical IT Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

• Clinical Staffing Services Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Key companies profiled

• IQVIA

• PAREXEL International Corporation

• Pharmaceutical Product Development

• Charles River Laboratory

• ICON Plc

• Syneos Health

• Chiltern International Ltd

• Eli Lilly and Company

• Pfizer

• Caidya

Brief about Pipeline by Grand View Research:

A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

Our services include (not limited to):

• Market Intelligence involving – market size and forecast, growth factors, and driving trends

• Price and Cost Intelligence – pricing models adopted for the category, total cost of ownerships

• Supplier Intelligence – rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing

• Sourcing / Procurement Intelligence – best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best suited countries for sourcing to minimize supply chain disruptions

[blog-site-for-market-research]

Navigating the Dynamics of Pharmaceutical Analytical Testing Outsourcing Market Industry

Market Overview –

The Pharmaceutical Analytical Testing Outsourcing Market is experiencing robust growth as pharmaceutical companies increasingly outsource their analytical testing needs to specialized service providers. Analytical testing is crucial in the pharmaceutical industry for ensuring the safety, quality, and efficacy of drug products.

Outsourcing Analytical Testing in the pharmaceutical industry is witnessing significant traction as companies seek cost-effective and specialized solutions. Outsourcing firms offer expertise in analytical testing, ensuring regulatory compliance and quality assurance. This trend is driven by the complexity of testing requirements and the need for efficient resource allocation. The market for outsourcing analytical testing services is expected to continue growing as pharmaceutical companies prioritize core activities and seek external expertise.

The market is driven by several factors, including the growing complexity of drug formulations, stringent regulatory requirements, and the need for specialized expertise and equipment. Outsourcing analytical testing allows pharmaceutical companies to access state-of-the-art facilities and specialized skills without making significant investments in infrastructure and personnel.

Moreover, outsourcing offers flexibility, scalability, and cost-effectiveness, enabling companies to streamline their operations and focus on core activities such as drug discovery and development. As a result, outsourcing analytical testing has become a strategic imperative for many pharmaceutical companies, driving the growth of the market.

Key players in the market range from contract research organizations (CROs) to specialized analytical testing laboratories, offering a wide range of services, including method development, validation, stability testing, and quality control.

The pharmaceutical analytical testing outsourcing market is also witnessing increasing demand from emerging markets, where pharmaceutical companies seek to leverage cost advantages and access local expertise. Additionally, the COVID-19 pandemic has further accelerated the adoption of outsourcing as companies strive to meet growing demand for testing services while managing disruptions to their operations.

Overall, the pharmaceutical analytical testing outsourcing market is expected to continue its expansion, driven by the growing demand for high-quality analytical services, regulatory compliance, and operational efficiency within the pharmaceutical industry.

In 2022, the pharmaceutical analytical testing outsourcing market was estimated to be worth USD 4.2 billion. According to projections, the pharmaceutical analytical testing outsourcing market is expected to increase at a compound annual growth rate (CAGR) of 8.70% from USD 4.6 billion in 2023 to USD 7.5 billion by 2030.

Segmentation –

The global pharmaceutical analytical testing outsourcing market, by product type, has been segmented into finished products, active pharmaceutical ingredients, and raw materials. The finished products segment accounted for a value of USD 2,055.4 million in 2017. The market, by services, can be segmented into bioanalytical testing, method development & validation, stability testing, and others. On the basis of end user, the global pharmaceutical analytical testing outsourcing market is segmented into pharmaceutical & biopharmaceutical companies and biotechnology industry.

Regional Analysis –

The Pharmaceutical Analytical Testing Outsourcing Market exhibits diverse regional trends influenced by factors such as regulatory frameworks, technological advancements, and the presence of outsourcing service providers.

North America dominates the market, driven by stringent regulatory requirements, a robust pharmaceutical industry, and a high demand for outsourcing services to ensure compliance and product quality. The region also benefits from a mature outsourcing ecosystem and a strong network of contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). Similarly, Europe holds a significant market share, supported by a well-established pharmaceutical sector, favorable regulatory environment, and increasing emphasis on cost-effective solutions.

In Asia Pacific, the market is witnessing rapid growth fueled by the outsourcing trend among pharmaceutical companies, expanding healthcare infrastructure, and a skilled workforce at competitive costs. Latin America and the Middle East & Africa regions present opportunities for market expansion, driven by the growing pharmaceutical industry, improving regulatory landscape, and cost advantages. However, challenges such as quality control issues and intellectual property concerns may impact market growth in these regions. Overall, the Pharmaceutical Analytical Testing Outsourcing Market showcases a dynamic landscape across different regions, characterized by varying regulatory environments, outsourcing capabilities, and market demands.

Key Players –

Pharmaceutical analytical testing outsourcing companies include Boston Analytical (New Hampshire), West Pharmaceutical Services, Inc. (U.S.), Exova Group PLC (U.K.), Source BioScience (U.K.), Pace Analytical Services, Inc. (U.S.), Merck KGaA (Germany), WuXi AppTec (U.S.), Toxikon (U.S.), Eurofins Scientific (Belgium and Luxembourg), Intertek Group Plc (U.K.), Charles River Laboratories International, Inc (U.S.), SGS SA (U.K.), and Pharmaceutical Product Development, LLC (U.S.).

Related Reports –

Oral Cancer Diagnostics

Automatic Pill Dispenser

Lancet

Medical Oxygen Concentrators

For more information visit at MarketResearchFuture

[poonamcmi]

Pharmaceutical Analytical Testing Market Is Estimated to Witness High Growth Owing to Increasing Emphasis on Test

Pharmaceutical analytical testing involves various activities such as testing of raw materials, packaging components, in-process testing as well as final product testing to ensure quality and safety standards. It helps in determining product identity, strength, quality and purity as well as identifying potential contaminants. Some common analytical testing methods used in pharmaceutical industry include chromatography, spectroscopy, titrimetry and physical tests. It plays a vital role in drug development and production by testing drug substances, excipients as well as final drug products. Increasing regulatory mandates pertaining to safety and efficacy of drugs have further accelerated the need for analytical testing in pharmaceutical industry.

The global pharmaceutical analytical testing market is estimated to be valued at US$ 8.41 Bn in 2024 and is expected to exhibit a CAGR of 8.7% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the pharmaceutical analytical testing are Alibaba Group Holding Limited, Redcentric Plc., Amazon Web Services, Inc., Rackspace Hosting, Inc., Dell EMC, Oracle Corporation, Google LLC, Microsoft Corporation, Hewlett Packard Enterprise Development LP, and International Business Machines Corporation. These major players are focusing on strengthening their presence through mergers and acquisitions as well as launching new testing technologies to enhance their market share.

The Pharmaceutical Analytical Testing Market Size include increasing scope of outsourcing testing activities, growing demand for specialized analytical testing from biopharmaceutical companies and uptake of automated analytical systems. Testing services providers are targeting these opportunities by expanding their geographical presence as well as service portfolio.

Globally, North America dominates the pharmaceutical analytical testing market due to stringent regulatory environment. However, Asia Pacific is expected to witness highest growth owing to increasing investments by international test providers as well as surge in domestic pharmaceutical manufacturing activities. Countries like China and India offer huge potential for outsourced pharmaceutical analytical testing.

Market Drivers Increasing emphasis on test efficiency and quality is a major growth driver for pharmaceutical analytical testing market. Rising need to lower testing costs amid price control regulations has prompted companies to adopt advanced automated analytical techniques and high-throughput systems. Growing complexity of drug molecules also necessitates analytical characterization at each stage of drug development and manufacturing, driving the demand for analytical testing services globally.

PEST Analysis

Political: Pharmaceutical Analytical Testing Market Size And Trends  are regulated by agencies like the US FDA and the EU EMA. Any changes in regulations can impact the type and frequency of testing required.

Economic: Growth in the pharmaceutical industry and increasing drug development activities drive the need for analytical testing services. Changes in the economic conditions can impact R&D spending by pharma companies.

Social: Increase in lifestyle diseases and an aging population are driving the demand for new drugs. This leads to higher need for analytical testing during drug development and manufacturing.

Technological: Adoption of newer tools like artificial intelligence and automation are helping speed up testing processes and data analysis. Technologies like biologics also require specialized analytical characterization techniques.

The Asia Pacific region is one of the largest and fastest growing markets for pharmaceutical analytical testing in terms of value. The Asia Pacific pharmaceutical market has been growing at a high rate led by economies like China, India and South Korea. The presence of major generic drug manufacturers has supported the growth of analytical testing outsourcing in this region.

North America is currently one of the most concentrated markets for pharmaceutical analytical testing globally. It accounts for the highest revenue share due to the large pharmaceutical industry, stringent regulatory requirements as well as the focus on new drug development by major players in the US and Canada. The rising complexity of analytical techniques required also contributes to the high testing expenditures in the region. Get More Insights On, Pharmaceutical Analytical Testing Market About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191

[neha24blog]

Pharmaceutical Analytical Testing Outsourcing Market Demand By Services, End Use Region And Forecast To 2030: Grand View Research Inc.

San Francisco, 14 Aug 2024: The Report Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development and Validation, Stability Testing), By End Use, By Region, And Segment Forecasts, 2024 – 2030 The global pharmaceutical analytical testing outsourcing market size was valued at USD 14.6 billion in 2030 and is…

[frontropharma]

Contract Research Organization in Delhi NCR

Welcome to FrontroPharma, a contract research organization in Delhi, India is your gateway to innovative solutions in clinical & contract research organization (CRO) services. Explore our diverse expertise across the pharmaceutical spectrum

In the ever-evolving world of clinical trials and pharmaceutical development, Contract Research Organizations (CROs) play a pivotal role. They provide a range of services that allow pharmaceutical, biotechnology, and medical device companies to outsource various stages of their research and development. As the demand for innovative healthcare solutions continues to grow, identifying the top contract research organization becomes crucial for the success of clinical projects. In this article, we will explore what makes a CRO stand out and highlight some of the leading names in the industry, including how FrontroPharma is paving the way.

A Contract Research Organization is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.These services include everything from clinical trial management to data analysis and regulatory compliance. CROs help companies to streamline their processes, reduce costs, and expedite the time to market for new drugs and medical devices.

Key Services Offered by Top Contract Research Organizations

At FrontroPharma, we pride ourselves on delivering comprehensive and tailored solutions to meet our clients’ unique needs. Here are the key services offered by top CROs:

Experience and Expertise: A proven track record of successful clinical trials and deep expertise in specific therapeutic areas.

Global Reach: Presence in multiple countries, enabling the conduct of multi-national trials and access to diverse patient populations.

Technological Capabilities: Utilization of cutting-edge technologies such as electronic data capture (EDC) systems and real-time data analytics.

Quality Assurance: Commitment to maintaining the highest standards of quality and compliance with regulatory requirements.

Client-Centric Approach: Customized solutions and a focus on building strong partnerships with clients.

Top Contract Research Organizations

Here are some of the top contract research organizations known for their excellence and innovation in the field: 1. frontro pharma We are heavily committed to regular investment in healthcare products that are innovative, highly effective, practical and easy to use, and are manufactured to the most demanding standards of quality, safety and efficacy. We aspire for quality, and constantly challenge ourselves and our methods. 2. Labcorp Drug Development Formerly known as Covance, Labcorp Drug Development provides a wide range of drug development and animal testing services. Their extensive experience and state-of-the-art facilities ensure high-quality results for clinical trials. 3. PPD (Pharmaceutical Product Development) PPD offers a full spectrum of services across all phases of pharmaceutical development. With a robust global network and deep therapeutic expertise, PPD is well-equipped to handle complex clinical trials. 4. Parexel Parexel is renowned for its patient-centric approach and commitment to reducing the time and cost of clinical trials. Their innovative solutions and extensive regulatory knowledge make them a leader in the industry. 5. ICON plc ICON plc specializes in providing outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. Their focus on innovation and efficiency sets them apart from other CROs.

Why Choose Frontro Pharma as Your CRO Partner?

At Frontro Pharma, we combine all the essential qualities of a top contract research organization. Our dedication to excellence, coupled with our innovative approaches and extensive industry experience, makes us the ideal partner for your clinical research needs.

Innovative Solutions: Leveraging the latest technology to streamline clinical trials and ensure data integrity.

Global Network: Conducting trials across multiple countries to access diverse patient populations and meet regulatory requirements worldwide.

Client Focus: Providing tailored solutions and maintaining strong, collaborative relationships with our clients.

FAQ Section

What are the benefits of working with a top contract research organization like Frontro Pharma? • Working with a top CRO can reduce costs, increase the speed of drug development, and ensure compliance with regulatory standards. How do I choose the right CRO for my project? • Consider factors such as the CRO’s experience, global reach, technological capabilities, and client reviews. What role do CROs play in regulatory affairs? • CROs assist with the preparation and submission of documents required by regulatory authorities, ensuring that clinical trials meet all regulatory requirements.

Conclusion

Choosing the top contract research organization is a critical decision that can significantly impact the success of a clinical trial. By considering factors such as experience, global reach, technological capabilities, and quality assurance, companies can identify a CRO that aligns with their needs and objectives. The organizations highlighted in this article represent some of the best in the industry, known for their excellence and innovation in clinical research. At Frontro Pharma, we are committed to providing top-tier CRO services that ensure the highest standards of quality and efficiency. Contact us today to learn more about how we can support your clinical research needs and bring new, life-saving treatments to market more quickly and effectively.

[healthcarehubhh]

The Gas Chromatography Market to grow at highest pace owing to widespread applications in drug discovery and development processes

The gas chromatography market involves the use of gas chromatographs for separation and analysis of mixtures. Gas chromatography is commonly used in analytical chemistry for separating and analyzing compounds that can be vaporized without decomposition. It works on the principle that different compounds move through a column at different rates depending on their molecular characteristics and affinity with the column’s stationary phase. Some key applications of gas chromatography include drug discovery and development, analysis of environmental pollutants, quality assurance in food and beverage industry. It offers several advantages over other analytical techniques like high reproducibility and accuracy, enhanced precision and resolution. The global demand for gas chromatography is rising significantly owing to increasing focus on advanced analytical methods in industries like pharmaceuticals and biotechnology. The Global Gas Chromatography Market is estimated to be valued at US$ $9.64 Bn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the Gas Chromatography are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Merck KgaA, PerkinElmer, Inc. Agilent Technologies, Inc. dominates the gas chromatography market with over 25% market share owing to its wide product portfolio. Growing demand from drug development and clinical research is a major factor boosting the gas chromatography industry. Pharmaceutical and biotech companies are increasingly adopting GC techniques to accelerate drug discovery processes. Stringent safety and quality regulations across industries are also propelling the demand.

Technological advancements like improved columns, detectors and software are enhancing efficiency and enabling high throughput screening. Miniaturization of gas chromatography systems has augmented their usage in point-of-care testing and on-field applications. Market Trends - Increasing popularity of hyphenated techniques: Combining gas chromatography with mass spectrometry is gaining significance as it provides confirmatory data and enhances sensitivity. - Upsurge in crude and shale oil production: Gas chromatography finds increasing usage in analyzing complex hydrocarbon mixtures obtained from crude oil refining and shale oil extraction. This is expected to drive the demand from oil and gas industry. Market Opportunities - Focus on food safety and authentication: Rising global food trade and recent adulteration incidents have heightened the need for reliable analytical methods for ensuring food safety. This presents opportunities for GC deployment in food testing labs. - Pharmaceutical applications: Growing drug pipelines, complex molecules and stringent regulations make gas chromatography an indispensable analytical technique. Increase in outsourcing of clinical trials and quality control to Asia and Latin America opens new expansion avenues. Impact of COVID-19 on the Gas Chromatography Market The COVID-19 pandemic has significantly impacted the growth of the gas chromatography market. During the initial outbreak, countries went under complete lockdown which disrupted the supply chain and halted production activities. This led to a significant decline in sales of gas chromatography instruments and consumables in 2020. Research and development activities were also put on hold as most laboratories were shut down during the peak of the pandemic.